Status:
COMPLETED
Efficacy Emollient on Xerosis in Children With Atopic Dermatitis
Lead Sponsor:
Pierre Fabre Medicament
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
2-6 years
Phase:
PHASE3
Brief Summary
Atopic dermatitis is a frequent, chronic inflammatory disease influenced by local, immunological, genetic and environmental factors. Important symptoms of atopic dermatitis are dry skin, intense pruri...
Eligibility Criteria
Inclusion
- Presenting with atopic dermatitis, dry skin, objective SCORAD \< 15,
- With xerosis on the body and a xerosis score \> = 2 (SCORAD sub-score) on the anterior part of lower limbs,
Exclusion
- Acute phase of atopic dermatitis
- Severe form of atopic dermatitis
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT01467362
Start Date
November 1 2011
End Date
May 1 2012
Last Update
February 21 2013
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Estonia
Tallinn, Estonia
2
Estonia
Tartu, Estonia
3
France
Bordeaux, France
4
France
Martigues, France